Biotech · Private company
Invirsa, Inc.
Track this companyFree. Adds Invirsa, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- INV-102Phase 2 · Acute Infectious KeratoconjunctivitisClinicalTrials.gov · fetched Nov 12, 2026
- INV-102Phase 2 · Dry Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- INV-102Phase 2 · Non-center Involved Diabetic Macular EdemaClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 2 · Acute Infectious KeratoconjunctivitisClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 2 · Dry Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Study of INV-102 Ophthalmic Solution in Adults With Diabetic Macular Edema Associated With Non-proliferative Diabetic RetinopathyPHASE2 · COMPLETED · started Sep 7, 2024ClinicalTrials.gov NCT06599684 · fetched Nov 12, 2026
- Study of INV-102 Ophthalmic Solution in Adults With Moderate to Severe Dry Eye DiseasePHASE2 · COMPLETED · started Mar 27, 2024ClinicalTrials.gov NCT06370039 · fetched Nov 12, 2026
- Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious KeratoconjunctivitisPHASE2 · COMPLETED · started Jun 9, 2023ClinicalTrials.gov NCT05636228 · fetched Nov 12, 2026
- Study of INV-102 Ophthalmic Solution in Adults With Moderate Symptomatic Dry Eye DiseasePHASE1_PHASE2 · COMPLETED · started Aug 30, 2022ClinicalTrials.gov NCT05586152 · fetched Nov 12, 2026